Xenon Pharmaceuticals Inc.·4

Aug 21, 4:48 PM ET

WINQUIST RAYMOND 4

4 · Xenon Pharmaceuticals Inc. · Filed Aug 21, 2017

Insider Transaction Report

Form 4
Period: 2017-08-18
WINQUIST RAYMOND
Head, Translational Research
Transactions
  • Purchase

    Common Shares

    2017-08-18$3.00/sh+1,000$2,9951,000 total

Documents

1 file
  • 4
    formfour.xmlPrimary

    OWNERSHIP DOCUMENT